The report on Amlodipine market offers an overview of several major countries spread across various geographic regions over the globe. The report concentrates on recognizing various market developments, dynamics, growth drivers and factors hampering the market growth. Further, the report delivers comprehensive insights into numerous growth opportunities and challenges based on various types of products, applications, end users and countries, among others.

Key Market Players
According to the global Amlodipine market analysis, the key players operating include

Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Shanghai Disainuo Biopharmaceutical
Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
Beijing Wansheng Pharmaceutical
Beijing Honglin Pharmaceutical
Beijing Maidihai Pharmaceutical
China Resources Saike Pharmaceutical
Beijing Jiulong Pharmaceutical
Tiannian Pharmaceutical
Chengdu Diao Pharmaceutical Group
Yangtze Pharmaceutical
Kunming Sino Pharmaceutical
Wuhan Dongxin Pharmaceutical Technology
Jiangsu Wangao Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Jiangsu Huanghe Pharmaceutical
Zhejiang Jingxin Pharmaceutical
Zhejiang Jianfeng Pharmaceutical
Hunan Qianjinxieli Pharmaceutical

Report Scope:
A complete interpretation of the global Amlodipine market

Attractive investment plans in the global Amlodipine market based on various segments such as product type, application, end user etc.
Important success factors and pain points in the form of growth drivers and restraints leading the market outlook along with future trend examination
In depth company profiles offering insights into their product offerings, strategies, revenue information and latest market activities
Information on industry value chain analysis of the global Amlodipine market providing an analytical study of key stakeholders involved, which could advance market participants in formulating appropriate strategies
Competitive landscape of the global Amlodipine market and market share analysis based on company’s performance and customer reach

Report Overview:
This study was conducted with a global viewpoint in terms of the various segments in the Amlodipine market. Market sizing and estimate have been conducted for 5 geographic regions: North America, Latin America, Europe, Middle East and Africa (MEA), and Asia-Pacific. All market sizing information is delivered in US$ with historic data for 2018 and 2019, along with valuations and forecast for the period from 2020 to 2028.
Apart from that, the report also provides important distinguishing information regarding each of the market segments. These segments are analyses further on different fronts such as historical performance, market size contributions, % market share, expected rate of growth.

COVID-19 Impact:
The report provides how this industry is likely to be impacted as a result of the global COVID-19 pandemic. Market value by revenue is expected to develop xx% in 2020 alone as demand is expected to be reasonably affected by the outbreak of COVID-19. The downstream companies contend with limited profit from falling consumer confidence, demand for industry products is expected to slow. Demand from top notch companies and government agencies is expected to grow as they seek more data on COVID-19. Almost, every sector is anticipated to be impacted by COVID-19 pandemic. Some of the industries are struggling and some are thriving.

Key Market Segmentation:
Amlodipine Market, by Type:

Amlodipine Benzene Sulfonate Tablet
Amlodipine Mesylate Tablet
Levoamlodipine Maleic Acid Tablet
by Form
Tablets
Capsule

Amlodipine Market, by Application:

High Blood Pressure
Angina Pectoris
Other

Amlodipine Market, by Geography:
On the basis of region, the global Amlodipine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regional segmentation consists of the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East and Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

1 Amlodipine Market Overview
1.1 Product Overview and Scope of Amlodipine
1.2 Amlodipine Segment by Type
1.2.1 Global Amlodipine Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Amlodipine Benzene Sulfonate Tablet
1.2.3 Amlodipine Mesylate Tablet
1.2.4 Levoamlodipine Maleic Acid Tablet
1.2.5 by Form
1.2.5.1 Tablets
1.2.5.2 Capsule
1.3 Amlodipine Segment by Application
1.3.1 Amlodipine Sales Comparison by Application: (2020-2026)
1.3.2 High Blood Pressure
1.3.3 Angina Pectoris
1.3.4 Other
1.4 Global Amlodipine Market Size Estimates and Forecasts
1.4.1 Global Amlodipine Revenue 2015-2026
1.4.2 Global Amlodipine Sales 2015-2026
1.4.3 Amlodipine Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Amlodipine Industry Impact
1.5.1 How the Covid-19 is Affecting the Amlodipine Industry
1.5.1.1 Amlodipine Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Amlodipine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures/Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Amlodipine Players to Combat Covid-19 Impact
1.6 Study Objectives
1.7 Years Considered

2 Global Amlodipine Market Competition by Manufacturers
2.1 Global Amlodipine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Amlodipine Revenue Share by Manufacturers (2015-2020)
2.3 Global Amlodipine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Amlodipine Manufacturing Sites, Area Served, Product Type
2.5 Amlodipine Market Competitive Situation and Trends
2.5.1 Amlodipine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Amlodipine Players (Opinion Leaders)

3 Amlodipine Retrospective Market Scenario by Region
3.1 Global Amlodipine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Amlodipine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Amlodipine Market Facts & Figures by Country
3.3.1 North America Amlodipine Sales by Country
3.3.2 North America Amlodipine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Amlodipine Market Facts & Figures by Country
3.4.1 Europe Amlodipine Sales by Country
3.4.2 Europe Amlodipine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Amlodipine Market Facts & Figures by Region
3.5.1 Asia Pacific Amlodipine Sales by Region
3.5.2 Asia Pacific Amlodipine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Amlodipine Market Facts & Figures by Country
3.6.1 Latin America Amlodipine Sales by Country
3.6.2 Latin America Amlodipine Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Amlodipine Market Facts & Figures by Country
3.7.1 Middle East and Africa Amlodipine Sales by Country
3.7.2 Middle East and Africa Amlodipine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Amlodipine Historic Market Analysis by Type
4.1 Global Amlodipine Sales Market Share by Type (2015-2020)
4.2 Global Amlodipine Revenue Market Share by Type (2015-2020)
4.3 Global Amlodipine Price Market Share by Type (2015-2020)
4.4 Global Amlodipine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Amlodipine Historic Market Analysis by Application
5.1 Global Amlodipine Sales Market Share by Application (2015-2020)
5.2 Global Amlodipine Revenue Market Share by Application (2015-2020)
5.3 Global Amlodipine Price by Application (2015-2020)

6 Company Profiles and Key Figures in Amlodipine Business
6.1 Novartis
6.1.1 Corporation Information
6.1.2 Novartis Description, Business Overview
6.1.3 Novartis Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Novartis Products Offered
6.1.5 Novartis Recent Development
6.2 Pfizer
6.2.1 Corporation Information
6.2.2 Pfizer Description, Business Overview
6.2.3 Pfizer Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Pfizer Products Offered
6.2.5 Pfizer Recent Development
6.3 Lek
6.3.1 Corporation Information
6.3.2 Lek Description, Business Overview
6.3.3 Lek Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Lek Products Offered
6.3.5 Lek Recent Development
6.4 TEVA
6.4.1 Corporation Information
6.4.2 TEVA Description, Business Overview
6.4.3 TEVA Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 TEVA Products Offered
6.4.5 TEVA Recent Development
6.5 Macleods Pharmaceuticals
6.5.1 Corporation Information
6.5.2 Macleods Pharmaceuticals Description, Business Overview
6.5.3 Macleods Pharmaceuticals Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Macleods Pharmaceuticals Products Offered
6.5.5 Macleods Pharmaceuticals Recent Development
6.6 Caraco Pharmaceutical
6.6.1 Corporation Information
6.6.2 Caraco Pharmaceutical Description, Business Overview
6.6.3 Caraco Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Caraco Pharmaceutical Products Offered
6.6.5 Caraco Pharmaceutical Recent Development
6.7 Sanis Health
6.7.1 Corporation Information
6.7.2 Sanis Health Description, Business Overview
6.7.3 Sanis Health Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.7.4 Sanis Health Products Offered
6.7.5 Sanis Health Recent Development
6.8 Jamp Pharma
6.8.1 Corporation Information
6.8.2 Jamp Pharma Description, Business Overview
6.8.3 Jamp Pharma Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Jamp Pharma Products Offered
6.8.5 Jamp Pharma Recent Development
6.9 Accel Pharma
6.9.1 Corporation Information
6.9.2 Accel Pharma Description, Business Overview
6.9.3 Accel Pharma Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Accel Pharma Products Offered
6.9.5 Accel Pharma Recent Development
6.10 Jubilant Generics
6.10.1 Corporation Information
6.10.2 Jubilant Generics Description, Business Overview
6.10.3 Jubilant Generics Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Jubilant Generics Products Offered
6.10.5 Jubilant Generics Recent Development
6.11 Angita Pharma
6.11.1 Corporation Information
6.11.2 Angita Pharma Description, Business Overview
6.11.3 Angita Pharma Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Angita Pharma Products Offered
6.11.5 Angita Pharma Recent Development
6.12 Florida DOH Central Pharmacy
6.12.1 Corporation Information
6.12.2 Florida DOH Central Pharmacy Description, Business Overview
6.12.3 Florida DOH Central Pharmacy Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Florida DOH Central Pharmacy Products Offered
6.12.5 Florida DOH Central Pharmacy Recent Development
6.13 Shanghai Disainuo Biopharmaceutical
6.13.1 Corporation Information
6.13.2 Shanghai Disainuo Biopharmaceutical Description, Business Overview
6.13.3 Shanghai Disainuo Biopharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Shanghai Disainuo Biopharmaceutical Products Offered
6.13.5 Shanghai Disainuo Biopharmaceutical Recent Development
6.14 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
6.14.1 Corporation Information
6.14.2 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Description, Business Overview
6.14.3 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Products Offered
6.14.5 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Recent Development
6.15 Beijing Wansheng Pharmaceutical
6.15.1 Corporation Information
6.15.2 Beijing Wansheng Pharmaceutical Description, Business Overview
6.15.3 Beijing Wansheng Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Beijing Wansheng Pharmaceutical Products Offered
6.15.5 Beijing Wansheng Pharmaceutical Recent Development
6.16 Beijing Honglin Pharmaceutical
6.16.1 Corporation Information
6.16.2 Beijing Honglin Pharmaceutical Description, Business Overview
6.16.3 Beijing Honglin Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Beijing Honglin Pharmaceutical Products Offered
6.16.5 Beijing Honglin Pharmaceutical Recent Development
6.17 Beijing Maidihai Pharmaceutical
6.17.1 Corporation Information
6.17.2 Beijing Maidihai Pharmaceutical Description, Business Overview
6.17.3 Beijing Maidihai Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Beijing Maidihai Pharmaceutical Products Offered
6.17.5 Beijing Maidihai Pharmaceutical Recent Development
6.18 China Resources Saike Pharmaceutical
6.18.1 Corporation Information
6.18.2 China Resources Saike Pharmaceutical Description, Business Overview
6.18.3 China Resources Saike Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.18.4 China Resources Saike Pharmaceutical Products Offered
6.18.5 China Resources Saike Pharmaceutical Recent Development
6.19 Beijing Jiulong Pharmaceutical
6.19.1 Corporation Information
6.19.2 Beijing Jiulong Pharmaceutical Description, Business Overview
6.19.3 Beijing Jiulong Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Beijing Jiulong Pharmaceutical Products Offered
6.19.5 Beijing Jiulong Pharmaceutical Recent Development
6.20 Tiannian Pharmaceutical
6.20.1 Corporation Information
6.20.2 Tiannian Pharmaceutical Description, Business Overview
6.20.3 Tiannian Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Tiannian Pharmaceutical Products Offered
6.20.5 Tiannian Pharmaceutical Recent Development
6.21 Chengdu Diao Pharmaceutical Group
6.21.1 Corporation Information
6.21.2 Chengdu Diao Pharmaceutical Group Description, Business Overview
6.21.3 Chengdu Diao Pharmaceutical Group Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.21.4 Chengdu Diao Pharmaceutical Group Products Offered
6.21.5 Chengdu Diao Pharmaceutical Group Recent Development
6.22 Yangtze Pharmaceutical
6.22.1 Corporation Information
6.22.2 Yangtze Pharmaceutical Description, Business Overview
6.22.3 Yangtze Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.22.4 Yangtze Pharmaceutical Products Offered
6.22.5 Yangtze Pharmaceutical Recent Development
6.23 Kunming Sino Pharmaceutical
6.23.1 Corporation Information
6.23.2 Kunming Sino Pharmaceutical Description, Business Overview
6.23.3 Kunming Sino Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.23.4 Kunming Sino Pharmaceutical Products Offered
6.23.5 Kunming Sino Pharmaceutical Recent Development
6.24 Wuhan Dongxin Pharmaceutical Technology
6.24.1 Corporation Information
6.24.2 Wuhan Dongxin Pharmaceutical Technology Description, Business Overview
6.24.3 Wuhan Dongxin Pharmaceutical Technology Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.24.4 Wuhan Dongxin Pharmaceutical Technology Products Offered
6.24.5 Wuhan Dongxin Pharmaceutical Technology Recent Development
6.25 Jiangsu Wangao Pharmaceutical
6.25.1 Corporation Information
6.25.2 Jiangsu Wangao Pharmaceutical Description, Business Overview
6.25.3 Jiangsu Wangao Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.25.4 Jiangsu Wangao Pharmaceutical Products Offered
6.25.5 Jiangsu Wangao Pharmaceutical Recent Development
6.26 Jiangsu Lianhuan Pharmaceutical
6.26.1 Corporation Information
6.26.2 Jiangsu Lianhuan Pharmaceutical Description, Business Overview
6.26.3 Jiangsu Lianhuan Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.26.4 Jiangsu Lianhuan Pharmaceutical Products Offered
6.26.5 Jiangsu Lianhuan Pharmaceutical Recent Development
6.27 Jiangsu Huanghe Pharmaceutical
6.27.1 Corporation Information
6.27.2 Jiangsu Huanghe Pharmaceutical Description, Business Overview
6.27.3 Jiangsu Huanghe Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.27.4 Jiangsu Huanghe Pharmaceutical Products Offered
6.27.5 Jiangsu Huanghe Pharmaceutical Recent Development
6.28 Zhejiang Jingxin Pharmaceutical
6.28.1 Corporation Information
6.28.2 Zhejiang Jingxin Pharmaceutical Description, Business Overview
6.28.3 Zhejiang Jingxin Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.28.4 Zhejiang Jingxin Pharmaceutical Products Offered
6.28.5 Zhejiang Jingxin Pharmaceutical Recent Development
6.29 Zhejiang Jianfeng Pharmaceutical
6.29.1 Corporation Information
6.29.2 Zhejiang Jianfeng Pharmaceutical Description, Business Overview
6.29.3 Zhejiang Jianfeng Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2015-2020)
6.29.4 Zhejiang Jianfeng Pharmaceutical Products Offered
6.29.5 Zhejiang Jianfeng Pharmaceutical Recent Development

7 Amlodipine Manufacturing Cost Analysis
7.1 Amlodipine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Amlodipine
7.4 Amlodipine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Amlodipine Distributors List
8.3 Amlodipine Customers

9 Market Dynamics
9.1 Market Overview
9.2 Market Trends
9.3 Market Inclination Insights Analysis
9.4 Drivers
9.5 Opportunities
9.6 Challenges
9.7 Future Prospects
9.8 Impact Analysis of Drivers and Challenges During the Forecast Period, (2018-2028)

10 Global Market Forecast
10.1 Global Amlodipine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Amlodipine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Amlodipine by Type (2021-2026)
10.2 Amlodipine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Amlodipine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Amlodipine by Application (2021-2026)
10.3 Amlodipine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Amlodipine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Amlodipine by Region (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

1836

Client base spread across 100+ countries - including 20% of Fortune 500 companies and 3000+ SMEs
4 Million+ Hours of Research Experience including 350+ Client Queries Handled Each Day
Incisive Insights into Market Dynamics – 2 Million+ Data Points, 1.2 Mn+ New Data Points Captured Each Year
Deeper Study, Minimal Assumptions – Years of Expertise and Diligence Incorporated

1836

Client base spread across 100+ countries - including 20% of Fortune 500 companies and 3000+ SMEs
4 Million+ Hours of Research Experience including 350+ Client Queries Handled Each Day
Incisive Insights into Market Dynamics – 2 Million+ Data Points, 1.2 Mn+ New Data Points Captured Each Year
Deeper Study, Minimal Assumptions – Years of Expertise and Diligence Incorporated

1836

Client base spread across 100+ countries - including 20% of Fortune 500 companies and 3000+ SMEs
4 Million+ Hours of Research Experience including 350+ Client Queries Handled Each Day
Incisive Insights into Market Dynamics – 2 Million+ Data Points, 1.2 Mn+ New Data Points Captured Each Year
Deeper Study, Minimal Assumptions – Years of Expertise and Diligence Incorporated

Our Research Methodology is based on the following main points:

Data Collections and Interpretation
Analysis
Data Validation
Final Projections and Conclusion

SELECT USER FORMAT

Single User: It allows one person, the buyer, to have sole right and access to the purchased report. Further distribution of product is strictly prohibited.
$2350
Multi User : It allows the purchased product to be shared among 5 people within your organization at maximum.
$3350
Corporate User : It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.
$4350

Why Zeal Insider?

Inflallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

Global Amlodipine Market By Product Type (Amlodipine Benzene Sulfonate Tablet, Amlodipine Mesylate Tablet) And By End-Users/Application (High Blood Pressure, Angina Pectoris) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

SELECT USER FORMAT

Why Zeal Insider?

Inflallible Methodology

Analyst Support

Customization

Targeted Market View

OUR CLIENT

About Company

Need Help

Contact Us

About Us